Sandoval Elisabeth 4
4 · VYNE Therapeutics Inc. · Filed Aug 12, 2022
Insider Transaction Report
Form 4
Sandoval Elisabeth
Director
Transactions
- Award
Stock Options
2022-08-10+20,500→ 20,500 totalExercise: $0.31Exp: 2032-08-10→ Common Stock (20,500 underlying)
Footnotes (1)
- [F1]Represents the annual award to non-executive directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest over a 12-month period in equal, monthly installments, ending August 10, 2023.